As US President Donald Trump prepares to unveil new reciprocal tariffs later this week, concerns are mounting in India, particularly within the pharmaceutical sector. Experts have raised alarms over the potential impact of these tariffs on India’s vital pharmaceutical exports, which are heavily reliant on the US Market. India exports more than $9 billion worth of pharmaceutical products to the US Annually, accounting for over 31% of the country’s total pharma exports.